Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

U.S. FDA Sends Warning Letter To Ozempen.com; FDA Observed That www.ozempen.com Introduces Into Interstate Commerce Unapproved And Misbranded Semaglutide Drug Products; Requests Cease Offering Any Unapproved And Misbranded Drugs For Sale To U.S. Consumers

Author: Benzinga Newsdesk | July 02, 2024 09:24am

- Reuters

Posted In: LLY NVO

07/05/2024 AXT, Inc. (AXTI)

07/05/2024 Altimmune, Inc. (ALT)

07/09/2024 Li Auto Inc. (LI)

07/12/2024 Inari Medical, Inc. (NARI)

07/12/2024 Sprout Social, Inc. (SPT)

07/16/2024 Vestis Corporation (VSTS)

07/22/2024 Biogen Inc. (BIIB)